Navigation Links
Proven Terumo Coronary Guidewire Technology Is Now Available in the United States
Date:9/12/2007

SOMERSET, N.J., Sept. 12 /PRNewswire/ -- Having already made great strides in Japan and Europe, Terumo's Runthrough NS Coronary Guidewire is ready to take on America.

Terumo Interventional Systems announces the launch of its breakthrough Runthrough(TM) NS Coronary Guidewire to the U.S. market. With its superior tip durability, complete torque transfer and enhanced steerability, this coronary guidewire boasts efficiency and reliability unlike that of other coronary guidewires. For use in percutaneous transluminal coronary angioplasties (PTCA), this product launch expands Terumo's expertise beyond the periphery and into the coronary space.

The primary difference between the Runthrough NS and other coronary guidewires is its exceptional tip shape retention. Because the tip retains its shape better than the leading coronary guidewires, as shown in head-to-head testing, the Runthrough NS gives physicians the ability to perform multi-vessel procedures with one wire. By making vessel selection and lesion crossing easier, the Runthrough NS may result in more efficient and cost-effective procedures.

"The tip is worth its weight in gold," said Dr. Richard Heuser, Chief of Cardiology with St. Luke's Medical Center, Phoenix, Arizona, who was involved in the U.S. trials of the Runthrough NS.

The Runthrough NS also features Terumo's unique DuoCore(TM) Technology. DuoCore fuses two proven guidewire technologies for one-to-one torque transfer and ensures excellent steerability, pushability and trackability. The fine tactile feel of the Runthrough NS also provides excellent guide and device support.

In addition, this first-choice coronary guidewire features the optimal balance of hydrophobic and hydrophilic coatings. The resultant smooth trackability in tortuous vessels and superior device delivery creates a significantly improved experience for the user.

"The balloon feels as if it is floating down the wire with absolutely no resistance,"
'/>"/>

SOURCE Terumo Interventional Systems
Copyright©2007 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3

Related medicine news :

1. TELITHROMYCIN - the proven effective new drug for cap
2. Partial-Breast Irradiation an Unproven Therapy
3. Drug-Coated Stents – Proven to be More Effectiv
4. “Provenge”, Dendritic cell vaccine for Prostate Cancr
5. Palatal Implant Procedure Proven Effective in Eliminating Snoring
6. New drug proven to tackle Type 2 Diabetes
7. No Proven Programs to Help Teens Quit Smoking
8. Young Adults Seldom Try Proven Methods to Kick the Butt
9. Clinically Proven Probiotic Supplement Now Available to Pharmacists
10. Transdermal HRT not cardioprotective in postmenopausal women with Coronary Artery Disease
11. Coronary stent leads to complications

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2009)...In a new study, the amount of television viewed by...s the previous estimates of early childhood screen...significantly more on average than those in center...ne screen time in child care settings in more than...168 child care programs in four states, and was gu...
(Date:11/22/2009)...On the skin,s surface, bacteria are abundant, dive... Research at the University of California, San Di...acteria living on the skin surface trigger a pathw...ry. , "These germs are actually good for us," sa...e and pediatrics, chief of UCSD,s Division of Derm...
(Date:11/22/2009)... The holiday season is fill...can be both fun and joyous. It can also be stressf...mbination of stress, fatigue, and high fat foods -...of cancer. That,s why the National Foundation for ...d Tips that can help ensure a happier, more health...
(Date:11/21/2009)..., , "This bill provides for an unprecede...is health care about if it is not for preserving a...ed, it must be defeated." Charmaine Yoest ,,...ericans United for Life Action President and CEO D...the Senate by releasing the following statement: ...
(Date:11/21/2009)... NH based medical credentia...st in its industry to form a partnerhsip with Amer....S. This partnership will help to transform quali... (Vocus) November 21, 2009 -- ISG Gr... announced a new agreement with Amerinet Inc., a l...
Breaking Medicine News(10 mins):Health News:Daycare may double TV time for young children, study finds 2Health News:Daycare may double TV time for young children, study finds 3Health News:Daycare may double TV time for young children, study finds 4Health News:Surface bacteria maintain skin's healthy balance 2Health News:Top 10 Food Tips for the Holidays from the National Foundation for Cancer Research 2Health News:Top 10 Food Tips for the Holidays from the National Foundation for Cancer Research 3Health News:Leading Anti-Abortion Group Vows to Vigorously Fight the Senate Health Bill 2Health News:IntelliSoft Group and Amerinet Inc. Form Partnership to Transform Healthcare Delivery of Quality Patient Safety and Care 2
...rs at the University of Chicago, reported that a b...e the risk of gastric cancer was present in as muc...tore. According to them, uncooked food leads to ma...ected with fecal matter. Christie Jack, a research...
... to researchers at the University of Texas, a new ...ress in a way that increases their risk of heart d...tally and emotionally stressful tasks,// having pr... increase arising from increased resistance within...
...tive test to detect colorectal cancer may be certa...archers in Boston, have developed a new technique ...stool that is only present in cancerous colorectal...he disease in its earlier stages. Colorectal ...
... to new research, a new drug that suppresses the i...abetes. An early-phase clinical trial of 10 people...ted with anti-CD3 mAb, a modified antibody.// A 14...abetes eventually lose the ability to produce insu...
... to researchers at the Puget Sound Health Care Sys...ave much lower levels of a recently discovered 'hu...those who lose weight by dieting.// Dr. David...may cut rates of obesity and related problems such...
... to a new study, shows that ulcer rates among diab... those wearing ordinary good quality footwear. Peo...oot care is an essential// part of managing their ...complications if left unattended. It's been ...
Other Medicine News:Health News:Decrease of 'Hunger Hormone' after Obesity Surgery 2
(Date:11/19/2009)... 19 The D e al magaz...Most Admired Corporate Dealmakers for the second c... Most Admired Dealmaker in pharma/biotech for the ...ivestitures since January 2006. ,, Over the pas...io with a focus on high-growth, innovation-driven ...
(Date:11/19/2009)...l Internet Week of Action ,, SILVER SPRING, Md...d and Drug Administration today completed a coordi...International Internet Week of Action (IIWA), inte...ducts. ,, (Logo: http://www.newscom.com/cgi-bi... the FDA,s Office of Criminal Investigations (OCI)...
(Date:11/19/2009)...19 Impliant, Inc., a developer of ...pinal fusion surgery, announced today that it has ...as the Vice President of Clinical and Regulatory A...gi-bin/prnh/20080527/NETU060LOGO ) ,, Mr. Rol...rience in the spinal and medical device field to I...
Breaking Medicine Technology:The Deal Names Abbott Top Dealmaker for Second Consecutive Year 2The Deal Names Abbott Top Dealmaker for Second Consecutive Year 3UPDATE: FDA Issues 22 Warning Letters to Web site Operators 2Impliant Announces the Addition of Vice President of Clinical and Regulatory Affairs to Executive Management Team 2Impliant Announces the Addition of Vice President of Clinical and Regulatory Affairs to Executive Management Team 3David Ebersman Joins Ironwood Board of Directors 57074 1David Ebersman Joins Ironwood Board of Directors 57074 2BeautiControl 28R 29 Encompasses Tupperware Brands Global Womens Initiative 3A Chain of Confidence 28R 29 57071 1BeautiControl 28R 29 Encompasses Tupperware Brands Global Womens Initiative 3A Chain of Confidence 28R 29 57071 2Common Diabetes Drug May Fight Cancer 57068 1Common Diabetes Drug May Fight Cancer 57068 2Common Diabetes Drug May Fight Cancer 57068 3
...gators to Assess BSI-201 Therapy in BRCA...lif., May 8 BiPar Sciences, Inc. today,announced ...or its lead,product, BSI-201, in ovarian cancer. T...hat BiPar has launched in the past 6 months, expan...., The company is evaluating BSI-201, the first p...
...nnounces the initiation of further clinical trials...ith an expected patient clinical group of 200,pati...Bryan of the Sports,Medicine Institute at The Meth...ordinate one clinical trial. Dr. Bryan was formerl...e former Medical Director of Major,League Baseball...
Other Medicine Technology:BiPar Sciences Expands Phase 2 Clinical Trials of BSI-201, a Novel DNA Repair Inhibitor, in Ovarian Cancer 2Go Healthy Initiates Additional Clinical Tests on Cholesterade 2
...The flexible cystoscope is being used more and mor... outstanding optical quality and large working/irr...le for both diagnostics and therapy. The outstandi...reatment is less stressful for the patient. ...
...The new EndoEYE Flexible Video Cystoscope from Oly...y. By marrying proprietary video chip technology w...mpus is now providing a flexible video cystoscope ...d rod lens system. As a result, this Flexible Vide...
...Olympus is proud to announce the next generation o...thing even better.,Now you have a choice between...YF-4A feature improved optics, an enlarged channel... instruments. In addition, the CYF-4A empowers the...
...The new OES Pro Cystoscope System incorporates the...sts the best instruments for diagnostic and therap...ables physicians and nurses to assemble the most d...ro Cystoscope System incorporates uses stainless s...
Medicine Products: